Why the study?
Does elevated CKMB mass concentration predict the risk of acute myocardial infarction or revascularization in patients with unstable angina pectoris?
Does elevated CKMB mass concentration predict the risk of acute myocardial infarction or revascularization in patients with unstable angina pectoris?
Elevated CKMB mass concentration, even when within the normal range, may serve as a valuable prognostic biomarker to identify high-risk patients with unstable angina.
May support CKMB measurement for risk stratification in unstable angina; leaves open whether it improves outcomes in prospective trials.
Unstable angina pectoris is a common clinical problem, and the diagnosis is based on clinical symptoms. However, these symptoms cannot identify high-risk patients. Holter monitoring can identify patients at high risk, but analysis of a large number of patients is time- and resource-consuming, as is angiographic examination. We determined whether creatine kinase MB isoenzyme mass concentration could predict the prognosis for patients with unstable angina pectoris. A total of 101 consecutive patients were studied, and blood samples were collected three times a day for 48 h after admission. Patients with unstable angina and elevated CKMB (but still within the normal range) had a significantly higher risk of developing acute myocardial infarction or requiring revascularization during 6 months of follow-up than patients without elevated CKMB. We conclude that CKMB analysis is a valuable tool that may be of use in selecting high-risk patients with unstable angina pectoris. This finding needs to be confirmed by more extensive studies.
No takes yet. Share an insight, caveat, or question.
Markenvard et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: